RxDoctor Payments DataLook up a doctor →

Akshay Muralidhar, MD

Critical Care Medicine · Scottsdale, AZNPI 1073856423

Payments from drug & device makers

$874,965in general payments, 2019–2025

Across 429 payments — averaging $2039.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$556K
  • Janssen Research & Development, LLC$181K
  • Sumitomo Pharma America, Inc.$94K
  • Novartis$20K
  • Actelion Pharmaceuticals US, Inc.$18K
  • Bayer$3K
  • plus $4K from 28 others

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$874,965 in reported general payments places this provider in the 95th percentile of 175 critical care medicine providers in Arizona.

See all critical care medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$236,778
Medicare patients
597
Services billed
2,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →